Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imaging-Reference-Cited by-同舟云学术

Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imaging

Published:2019-04-29 Issue:5 Volume:15 Page:
ISSN:1573-3882
Container-title:Metabolomics
language:en
Short-container-title:Metabolomics

Author:

Davison A. S.^ORCID,Strittmatter N.,Sutherland H.,Hughes A. T.,Hughes J.,Bou-Gharios G.,Milan A. M.,Goodwin R. J. A.,Ranganath L. R.,Gallagher J. A.

Funder

University of Liverpool

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s11306-019-1531-4.pdf

Reference34 articles.

1. Abbassi-Ghadi, N., Jones, E. A., Veselkov, K. A., Huang, J., Kumar, S., Strittmatter, N., et al. (2015). Repeatability and reproducibility of desorption electrospray ionization-mass spectrometry (DESI-MS) for the imaging analysis of human cancer tissue: a gateway for clinical applications. Analytical Methods, 7(1), 71–80.

2. Andreou, D., Söderman, E., Axelsson, T., Sedvall, G. C., Terenius, L., Agartz, et al. (2015). Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis. Psychiatry Research, 229(1–2), 497–504.

3. Borah, A., & Mohanakumar, K. P. (2012). L-DOPA induced-endogenous 6-hydroxydopamine is the cause of aggravated dopaminergic neurodegeneration in Parkinson’s disease patients. Medical Hypotheses, 79(2), 271–273.

4. Breese, G. R., Knapp, D. J., Criswell, H. E., Moy, S. S., Papadeas, S. T., & Blake, B. L. (2005). The neonate-6-hydroxydopamine-lesioned rat: A model for clinical neuroscience and neurobiological principles. Brain Research Reviews, 48(1), 57–73.

5. Davison, A. S., Harrold, J. A., Hughes, G., Norman, B. P., Devine, J., Usher, J., et al. (2018a). Clinical and biochemical assessment of depressive symptoms in patients with Alkaptonuria before and after two years of treatment with nitisinone. Molecular Genetics and Metabolism, 125(1–2), 135–143.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12 cells. Implications for treatment of phenylketonuria, tyrosinemia type 1 and comorbid neurodevelopmental disorders;Neurochemistry International;2023-12

2. Seeing the invisible: Preparative strategies to visualise elusive molecules using mass spectrometry imaging;TrAC Trends in Analytical Chemistry;2023-11

3. The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12 cells. Implications for treatment of phenylketonuria and tyrosinemia type 1;2023-09-05

4. Structure-Function Relationship of Homogentisate 1,2-dioxygenase: Understanding the Genotype-Phenotype Correlations in the Rare Genetic Disease Alkaptonuria;Current Protein & Peptide Science;2023-06

5. Increased prevalence of Parkinson's disease in alkaptonuria;JIMD Reports;2023-05-11